Global Dacryocystitis Treatment Market Trends, Size By Product (Oral Antibiotics, Systemic Antibiotics, Surgery, and Other), By Application (Acute Dacryocystitis, Chronic Dacryocystitis, Congenital Dacryocystitis, and Other), By End-user (Hospitals, Ambulatory Surgical Centers, Eye Care Centers, Retail Pharmacies, Drug Stores, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Dacryocystitis Treatment Market
The Global Dacryocystitis Treatment Market was valued at US$ 188.4 Mn in 2022, estimated to reach US$ 206.3 Mn by 2030, with a CAGR of 2.29% from 2023-2030.
Lacrimal gland (tear sac) irritation is referred to as dacryocystitis. It is brought on by nasolacrimal duct occlusion, which leads to stagnation in the lacrimal sac. These infections can be either chronic or acute. Pain, redness, and swelling across the inner portion of the lower eyelid and epiphora are some of its symptoms. Infants and adults over the age of 40 are typically the ones that contract these diseases. Treatment options include oral antibiotics, systemic antibiotics (in the majority of difficult cases), and surgery for recurrent infections depending on the type of dacryocystitis present.
Market Drivers
Increase in eye infections' frequency is one of the major factor driving the market growth during the forecast period. The market for treating dacryocystitis is anticipated to develop as a result of increased clinical research and subsequent new product introductions. The dacryocystitis treatment market is predicted to rise due to scientific developments in developed economies. It is also a significant contributor to ocular morbidity in both children and adults. Therefore, it necessitates special consideration for the earliest possible start of the right treatment.
Market Restraints
However, it is anticipated that poor healthcare spending may constrain the market for dacryocystitis treatments in underdeveloped nations. The market for treating dacryocystitis may have growth barriers due to lower patient awareness of various treatment options.
Market Segmentation
The scope of the Global Dacryocystitis Treatment Market covers segmentation based on Product Consulting Type of Brain Cancer, Therapy, and Region.
Based on Product, the market is classified into Oral Antibiotics, Systemic Antibiotics, Surgery, and Other.
Based on Application, the market is divided into Acute Dacryocystitis, Chronic Dacryocystitis, Congenital Dacryocystitis, and Other.
Based on End-user, the market is bifurcated into Hospitals, Ambulatory Surgical Centers, Eye Care Centers, Retail Pharmacies, Drug Stores, and Others.
Regional Analysis
The Global Dacryocystitis Treatment Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America estimated to lead the market in terms of considerable growth. The well-developed healthcare sector and the existence of top medical laser manufacturers are both factors contributing to the market's growth in the region. The two main nations in the area that significantly contribute to the market's expansion are the US and Canada.
In Addition, due to several government initiatives, reforms, laws, and regulations supporting the sophisticated treatment of eyes, the US is the market's largest contributor. During the projected period, quick R&D in relation to dacryocystitis is likely to have a substantial impact on market growth.
Key Players
Pfizer Inc., Cigna, Novartis International AG, Akorn Inc., Alembic Pharmaceuticals.
Market Taxonomy
By Product
• Oral Antibiotics
• Systemic Antibiotics
• Surgery
• Other
By Application
• Acute Dacryocystitis
• Chronic Dacryocystitis
• Congenital Dacryocystitis
• Other
By End-user
• Hospitals
• Ambulatory Surgical Centers
• Eye Care Centers
• Retail Pharmacies
• Drug Stores
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Bonsai Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
Global Dacryocystitis Treatment Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Dacryocystitis Treatment Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Dacryocystitis Treatment Market, By Product
5.1 Y-o-Y Growth Comparison, By Application and Services
5.2 Global Dacryocystitis Treatment Market Share Analysis, By Product
5.3 Global Dacryocystitis Treatment Market Size and Forecast, By Product
5.3.1 Oral Antibiotics
5.3.2 Systemic Antibiotics
5.3.3 Surgery
5.3.4 Other
6 Global Dacryocystitis Treatment Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Dacryocystitis Treatment Market Share Analysis, By Application
6.3 Global Dacryocystitis Treatment Market Size and Forecast, By Application
6.3.1 Acute Dacryocystitis
6.3.2 Chronic Dacryocystitis
6.3.3 Congenital Dacryocystitis
6.3.4 Other
7.Surgical Instruments Market, By End-user
7.1 Y-o-Y Growth Comparison, By End-user
7.2 Global Dacryocystitis Treatment Market Share Analysis, By End-user
7.3 Global Dacryocystitis Treatment Market Size and Forecast, By End-user
7.3.1 Hospitals
7.3.2 Ambulatory Surgical Centers
7.3.3 Eye Care Centers
7.3.4 Retail Pharmacies
7.3.5 Drug Stores
7.3.6 Others
8 Global Dacryocystitis Treatment Market, By Region
8.1 Global Dacryocystitis Treatment Market Share Analysis, By Region
8.2 Global Dacryocystitis Treatment Market Size and Forecast, By Region
8.3 Global Dacryocystitis Treatment Market Trends and Forecast, By Region
9 North America Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Dacryocystitis Treatment Market Share Analysis, By Product
9.3 North America Dacryocystitis Treatment Market Size and Forecast, By Application
9.4 North America Dacryocystitis Treatment Market Size and Forecast, By End-user
9.5 North America Dacryocystitis Treatment Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Product
9.5.1.2 Market Size and Forecast, By Application
9.5.1.3 Market Size and Forecast, By End-user
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Product
9.5.2.2 Market Size and Forecast, By Application
9.5.2.3 Market Size and Forecast, By End-user
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Product
9.5.3.2 Market Size and Forecast, By Application
9.5.3.3 Market Size and Forecast, By End-user
10 Europe Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Dacryocystitis Treatment Market Share Analysis, By Product
10.3 Europe Dacryocystitis Treatment Market Size and Forecast, By Application
10.4 Europe Dacryocystitis Treatment Market Size and Forecast, By End-user
10.5 Europe Dacryocystitis Treatment Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Product
10.5.1.2 Market Size and Forecast, By Application
10.5.1.3 Market Size and Forecast, By End-user
10.5.2 France
10.5.2.1 Market Size and Forecast, By Product
10.5.2.2 Market Size and Forecast, By Application
10.5.2.3 Market Size and Forecast, By End-user
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Product
10.5.3.2 Market Size and Forecast, By Application
10.5.3.3 Market Size and Forecast, By End-user
10.5.4. Russia
10.5.4.1 Market Size and Forecast, By Product
10.5.4.2 Market Size and Forecast, By Application
10.5.4.3 Market Size and Forecast, By End-user
10.5.5. Italy
10.5.5.1 Market Size and Forecast, By Product
10.5.5.2 Market Size and Forecast, By Application
10.5.5.3 Market Size and Forecast, By End-user
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Product
10.5.6.2 Market Size and Forecast, By Application
10.5.6.3 Market Size and Forecast, By End-user
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Product
10.5.7.2 Market Size and Forecast, By Application
10.5.7.3 Market Size and Forecast, By End-user
11 Asia Pacific Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Dacryocystitis Treatment Market Share Analysis, By Product
11.3 Asia Pacific Dacryocystitis Treatment Market Size and Forecast, By Application
11.4 Asia Pacific Dacryocystitis Treatment Market Size and Forecast, By End-user
11.5 Asia Pacific Dacryocystitis Treatment Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Product
11.5.1.2 Market Size and Forecast, By Application
11.5.1.3 Market Size and Forecast, By End-user
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Product
11.5.2.2 Market Size and Forecast, By Application
11.5.2.3 Market Size and Forecast, By End-user
11.5.3 India
11.5.3.1 Market Size and Forecast, By Product
11.5.3.2 Market Size and Forecast, By Application
11.5.3.3 Market Size and Forecast, By End-user
11.5.4. South Korea
11.5.4.1 Market Size and Forecast, By Product
11.5.4.2 Market Size and Forecast, By Application
11.5.4.3 Market Size and Forecast, By End-user
11.5.5. Australia
11.5.5.1 Market Size and Forecast, By Product
11.5.5.2 Market Size and Forecast, By Application
11.5.5.3 Market Size and Forecast, By End-user
11.5.6. New Zealand
11.5.6.1 Market Size and Forecast, By Product
11.5.6.2 Market Size and Forecast, By Application
11.5.6.3 Market Size and Forecast, By End-user
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Product
11.5.7.2 Market Size and Forecast, By Application
11.5.7.3 Market Size and Forecast, By End-user
11.5.8. Malaysia
11.5.8.1 Market Size and Forecast, By Application and Services
11.5.8.2 Market Size and Forecast, By Application
11.5.8.3 Market Size and Forecast, By End-user
11.5.9 Rest of Asia
11.5.9.1 Market Size and Forecast, By Product
11.5.9.2 Market Size and Forecast, By Application
11.5.9.3 Market Size and Forecast, By End-user
12 Latin America Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Dacryocystitis Treatment Market Share Analysis, By Product
12.3 Latin America Dacryocystitis Treatment Market Size and Forecast, By Application
12.4 Latin America Dacryocystitis Treatment Market Size and Forecast, By End-user
12.5 Latin America Dacryocystitis Treatment Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Product
12.5.1.2 Market Size and Forecast, By Application
12.5.1.3 Market Size and Forecast, By End-user
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Product
12.5.2.2 Market Size and Forecast, By Application
12.5.2.3 Market Size and Forecast, By End-user
12.5.3. Colombia
12.5.3.1 Market Size and Forecast, By Product
12.5.3.2 Market Size and Forecast, By Application
12.5.3.3 Market Size and Forecast, By End-user
12.5.4. Peru
12.5.4.1 Market Size and Forecast, By Product
12.5.4.2 Market Size and Forecast, By Application
12.5.4.3 Market Size and Forecast, By End-user
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Product
12.5.5.2 Market Size and Forecast, By Application
12.5.5.3 Market Size and Forecast, By End-user
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Product
12.5.6.2 Market Size and Forecast, By Application
12.5.6.3 Market Size and Forecast, By End-user
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Product
12.5.7.2 Market Size and Forecast, By Application
12.5.7.3 Market Size and Forecast, By End-user
13 Middle East Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Dacryocystitis Treatment Market Share Analysis, By Product
13.3 Middle East Dacryocystitis Treatment Market Size and Forecast, By Application
13.4 Middle East Dacryocystitis Treatment Market Size and Forecast, By End-user
13.5 Middle East Dacryocystitis Treatment Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Product
13.5.1.2 Market Size and Forecast, By Application
13.5.1.3 Market Size and Forecast, By End-user
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Product
13.5.2.2 Market Size and Forecast, By Application
13.5.2.3 Market Size and Forecast, By End-user
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Product
13.5.3.2 Market Size and Forecast, By Application
13.5.3.3 Market Size and Forecast, By End-user
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By Product
13.5.4.2 Market Size and Forecast, By Application
13.5.4.3 Market Size and Forecast, By End-user
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Product
13.5.5.2 Market Size and Forecast, By Application
13.5.5.3 Market Size and Forecast, By End-user
13.5.5 Rest of Middle East & Africa
13.5.6.1 Market Size and Forecast, By Product
13.5.6.2 Market Size and Forecast, By Application
13.5.6.3 Market Size and Forecast, By End-user
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Pfizer Inc.
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Cigna
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Novartis International AG
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Akorn Inc.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Alembic Pharmaceuticals
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
